These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 481951)

  • 1. Ornithine transcarbamylase deficiency in mutant mice I. Studies on the characterization of enzyme defect and suitability as animal model of human disease.
    Qureshi IA; Letarte J; Ouellet R
    Pediatr Res; 1979 Jul; 13(7):807-11. PubMed ID: 481951
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new family with mutation of the structural gene of human ornithine carbamoyltransferase].
    Stoll C; Bieth R; Dreyfus J; Flori E; Lutz P; Levy JM
    Arch Fr Pediatr; 1978 May; 35(5):512-8. PubMed ID: 678030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous animal models of ornithine transcarbamylase deficiency: studies on serum and urinary nitrogenous metabolites.
    Qureshi IA; Letarte J; Ouellet R
    Adv Exp Med Biol; 1982; 153():173-83. PubMed ID: 7164896
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperammonemia due to a defect in hepatic ornithine transcarbamylase.
    Sunshine P; Lindenbaum JE; Levy HL; Freeman JM
    Pediatrics; 1972 Jul; 50(1):100-11. PubMed ID: 5038084
    [No Abstract]   [Full Text] [Related]  

  • 5. Study of enzyme defect in a case of ornithine transcarbamylase deficiency.
    Qureshi IA; Letarte J; Quellet R
    Diabete Metab; 1978 Dec; 4(4):239-41. PubMed ID: 729890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of ornithine transcarbamylase deficiency in adult spf(ash) mice and in OTC-deficient human hepatocytes with recombinant adenoviruses bearing the CAG promoter.
    Kiwaki K; Kanegae Y; Saito I; Komaki S; Nakamura K; Miyazaki JI; Endo F; Matsuda I
    Hum Gene Ther; 1996 May; 7(7):821-30. PubMed ID: 8860834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of female carriers of ornithine-carbamyl-transferase deficiency by measurement of orotic acid in the urine].
    Dhondt JL; Farriaux JP
    Lille Med; 1975 Oct; 20(8):727-30. PubMed ID: 1219292
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and biochemical heterogeneity in females of a large pedigree with ornithine transcarbamylase deficiency due to the R141Q mutation.
    Ahrens MJ; Berry SA; Whitley CB; Markowitz DJ; Plante RJ; Tuchman M
    Am J Med Genet; 1996 Dec; 66(3):311-5. PubMed ID: 8985493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytes.
    Morsy MA; Zhao JZ; Ngo TT; Warman AW; O'Brien WE; Graham FL; Caskey CT
    J Clin Invest; 1996 Feb; 97(3):826-32. PubMed ID: 8609240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sparse fur mouse as a model for gene therapy in ornithine carbamoyltransferase deficiency.
    Batshaw ML; Yudkoff M; McLaughlin BA; Gorry E; Anegawa NJ; Smith IA; Hyman SL; Robinson MB
    Gene Ther; 1995 Dec; 2(10):743-9. PubMed ID: 8750014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Variability of enzyme activity and urinary orotic acid in ornithine transcarbamylase deficient spf/+ heterozygotic mice].
    Qureshi IA; Letarte J; Lebel S; Ouellet R
    Diabete Metab; 1986 Oct; 12(5):250-5. PubMed ID: 3803679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seven new mutations in the human ornithine transcarbamylase gene.
    Tuchman M; Plante RJ; McCann MT; Qureshi AA
    Hum Mutat; 1994; 4(1):57-60. PubMed ID: 7951259
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel missense mutation in the exon containing the putative ornithine-binding domain of the OTC enzyme in a female.
    Demmer LA; Kim JM; de Martinville B; Dowton SB
    Hum Mutat; 1996; 7(3):279. PubMed ID: 8829665
    [No Abstract]   [Full Text] [Related]  

  • 14. Ornithine transcarbamylase deficiency in male adolescence and adulthood.
    Yoshino M; Nishiyori J; Yamashita F; Kumashiro R; Abe H; Tanikawa K; Ohno T; Nakao K; Kaku N; Fukushima H
    Enzyme; 1990; 43(3):160-8. PubMed ID: 2095337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA diagnosis of ornithine transcarbamylase deficiency by PCR method].
    Matsuura T; Matsuda I
    Tanpakushitsu Kakusan Koso; 1990 Dec; 35(17):3113-9. PubMed ID: 2287729
    [No Abstract]   [Full Text] [Related]  

  • 16. Ornithine transcarbamylase deficiency: enzyme studies on a further case and a method of diagnosis using plasma enzyme ratios.
    Gray RG; Black JA; Lyons VH; Pollitt RJ
    Pediatr Res; 1976 Nov; 10(11):918-23. PubMed ID: 980551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic counseling in ornithine carbamoyltransferase deficiency].
    Pelet A; Toumas E; Rabier D; Kaplan J; Kamoun P; Frezal J; Saudubray JM; Munnich A
    Ann Biol Clin (Paris); 1988; 46(7):455-9. PubMed ID: 2903704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperammonemia due to a mutant enzyme of ornithine transcarbamylase.
    Matsuda I; Arashima S; Nambu H; Takekoshi Y; Anakura M
    Pediatrics; 1971 Oct; 48(4):595-600. PubMed ID: 5114747
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerebral dysfunction in asymptomatic carriers of ornithine transcarbamylase deficiency.
    Batshaw ML; Roan Y; Jung AL; Rosenberg LA; Brusilow SW
    N Engl J Med; 1980 Feb; 302(9):482-5. PubMed ID: 7351973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sparse-fur mutation: a model for some human ornithine transcarbamylase deficiencies.
    Briand P; Cathelineau L
    Adv Exp Med Biol; 1982; 153():185-94. PubMed ID: 6819764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.